消息面上,RBC Capital Markets最新研报指出,ICON已重新建立通往中个位数有机增长的"可信"路径,Q1订单出货比达1.42倍,超出市场与RBC预期,直接费用部分超过1.3倍,主要受全服务制药及生物技术客户订单驱动。RBC同时指出Q2管线"明显强劲",增强了持续复苏的信心。此前公司Q1调整后每股收益2.50美元,超FactSet一致预期2.43美元;收入20.3亿美元,亦高于预期。此外,公司于6月22日宣布选定微软为首选技术合作伙伴,部署Microsoft 365 Copilot并加速智能体AI平台Orbis落地。业绩兑现、投行背书与AI战略三重催化共振,推动股价持续走强。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.